Randall Pellish

Randall Pellish practices at Lahey Clinic in Burlington, Massachusetts, part of Beth Israel Lahey Health.

Randall Pellish's NPI, 1962629105, was assigned on April 19, 2007. Randall Pellish holds Massachusetts license 234728.

Randall Pellish's primary practice is Lahey Clinic, at 41 & 45 Mall Road, Burlington, MA 01803 in Middlesex County. The practice phone is (781) 744-5100.

Randall Pellish's primary practice is Lahey Clinic in Burlington, Massachusetts, part of Beth Israel Lahey Health. Randall Pellish is also affiliated with Beth Israel Deaconess Medical Center. The medical group on file is Lahey Clinic. Dmand AI also links Randall Pellish to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Randall Pellish practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Randall Pellish's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Randall Pellish's licenses on file in 2 states: Massachusetts and Rhode Island.

CMS data shows 448 Medicare services from Randall Pellish across 13 procedure codes in 2024, for 319 Medicare patients. Medicare paid $45,534 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 319 Medicare patients who saw Randall Pellish in 2024. The largest group is 65 to 74, with 135 patients. 72% of them have high blood pressure, and 70% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Randall Pellish's median patient age at 68, with 45% women.

In 2024, Randall Pellish wrote 594 Medicare Part D claims for 128 patients. 58% of them were for generic drugs. CMS names the drug for 426 of them, across 14 drugs with 11 or more claims each, at $2,237,567 in total drug cost. In 2023, CMS named 385 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Randall Pellish for performance year 2024, reported through an alternative payment model (APM). Randall Pellish accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Randall Pellish as offering telehealth. CMS counts 110 procedures of colonoscopy by Randall Pellish, more than 82% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Randall Pellish, published from 2015 to 2023. 2023 was the busiest year, with 3. The most frequent topics are Colitis, Ulcerative, Crohn Disease and Inflammatory Bowel Diseases. Randall Pellish has published most often in Inflamm Bowel Dis. Randall Pellish's most frequent co-authors are Adam S. Cheifetz, MD, Samuel Y. Han, MD and Veronica N. Baptista, MD.

Dmand AI links Randall Pellish to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Clostridium Infections, Crohn Disease and Gram-Positive Bacterial Infections.

CMS Open Payments shows 12 general payments to Randall Pellish from 7 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 87% of the total. Abbvie Inc. paid the most, $2,888.